Literature DB >> 20599870

Mitochondrial dysfunction in skin biopsies and blood mononuclear cells from two cases of fibromyalgia patients.

Mario D Cordero1, Ana M Moreno-Fernández, María I Carmona-López, José Antonio Sánchez-Alcázar, Ana Fernández Rodríguez, Plácido Navas, Manuel de Miguel.   

Abstract

OBJECTIVES: Coenzyme Q(10) (CoQ(10)) is an essential electron carrier in the mitochondrial respiratory chain and a strong antioxidant. Signs associated with skin alteration and mitochondrial dysfunction have been observed in patients with fibromyalgia (FM). The aim of this study was to analyze CoQ(10) levels, mitochondrial dysfunction, and oxidative stress in plasma, blood mononuclear cells, and skin biopsies from FM patients.
METHODS: We studied CoQ(10) level by HPLC in plasma, blood mononuclear cells, and skin obtained from patients with FM and healthy control subjects. Oxidative stress markers and mitochondrial respiratory chain enzyme activities were analysed in both plasma, blood mononuclear cells, and skin biopsies from FM patients.
RESULTS: Oxidative stress, mitochondrial dysfunction, and CoQ(10) deficiency have been observed in blood mononuclear cells and skin biopsies.
CONCLUSIONS: In our patients, mitochondrial dysfunction and CoQ(10) deficiency are present in several tissues. These results may contribute to the understanding of the pathophysiology of FM, and, moreover, CoQ(10) deficiency could represent a good marker for the diagnosis of FM. Copyright (c) 2010 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20599870     DOI: 10.1016/j.clinbiochem.2010.06.013

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  6 in total

1.  Dermatologic manifestations of fibromyalgia.

Authors:  Valerie Laniosz; David A Wetter; Desiree A Godar
Journal:  Clin Rheumatol       Date:  2014-01-14       Impact factor: 2.980

Review 2.  Coenzyme Q10 depletion in medical and neuropsychiatric disorders: potential repercussions and therapeutic implications.

Authors:  Gerwyn Morris; George Anderson; Michael Berk; Michael Maes
Journal:  Mol Neurobiol       Date:  2013-06-13       Impact factor: 5.590

Review 3.  Fibromyalgia: A Critical and Comprehensive Review.

Authors:  Andrea T Borchers; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2015-10       Impact factor: 8.667

4.  Pharmacotherapy for fibromyalgia.

Authors:  Howard S Smith; Donna Bracken; Joshua M Smith
Journal:  Front Pharmacol       Date:  2011-03-31       Impact factor: 5.810

5.  Fibromyalgia syndrome: metabolic and autophagic processes in intermittent cold stress mice.

Authors:  Lisa Oezel; Hanna Then; Anna L Jung; Samir Jabari; Gabriel A Bonaterra; Thaddeus T Wissniowski; Susanne F Önel; Matthias Ocker; Kati Thieme; Ralf Kinscherf; Pietro Di Fazio
Journal:  Pharmacol Res Perspect       Date:  2016-09-27

6.  Ambroxol for the treatment of fibromyalgia: science or fiction?

Authors:  Kai-Uwe Kern; Myriam Schwickert
Journal:  J Pain Res       Date:  2017-08-16       Impact factor: 3.133

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.